This webinar, “Your Guide to 2025: Pharma, Formularies, the Pipeline and More” featured Luke Greenwalt, MBA,vice president and lead of the Market Access Center of Excellence at IQVIA, an Jeff Casberg, RPh, M.S., senior vice president, clinical pharmacy at IPD Analytics. Greenwalt and Casberg, both of whom are on the Managed Healthcare Executive editorial advisory board, discussed the market trends for GLP-1s and biosimilars; the ’25 drug pipeline; and the prospects for PBM legislation.